US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist
  • 1.560
  • -0.010-0.64%
Close Dec 20 16:00 ET
  • 1.550
  • -0.010-0.64%
Post 20:01 ET
41.38MMarket Cap-1.46P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-60.62%55.18K
0
0
0
22.61%55.18K
-15.08%140.11K
0
Operating revenue
--0
--0
--0
-58.40%55.18K
--0
--0
--0
47.00%55.18K
-0.96%132.64K
--0
Cost of revenue
Gross profit
Operating expense
-8.72%4.46M
5.84%8.18M
-17.17%4.38M
24.51%22.31M
-3.38%4.41M
2.82%4.89M
46.66%7.73M
58.54%5.28M
28.06%17.92M
40.26%4.56M
Selling and administrative expenses
-27.02%1.84M
0.05%3.75M
-24.98%1.87M
13.08%10.79M
-11.11%2.03M
-9.64%2.52M
39.19%3.74M
40.33%2.49M
39.74%9.54M
28.54%2.29M
-General and administrative expense
-27.02%1.84M
0.05%3.75M
-24.98%1.87M
13.08%10.79M
-11.11%2.03M
-9.64%2.52M
39.19%3.74M
40.33%2.49M
39.74%9.54M
28.54%2.29M
Research and development costs
10.74%2.62M
11.28%4.44M
-10.19%2.51M
37.52%11.52M
4.40%2.37M
20.50%2.37M
54.44%3.99M
79.33%2.79M
16.93%8.38M
54.42%2.27M
Operating profit
8.72%-4.46M
-5.84%-8.18M
16.29%-4.38M
-25.18%-22.25M
3.38%-4.41M
-2.82%-4.89M
-49.35%-7.73M
-59.03%-5.23M
-28.58%-17.78M
-42.15%-4.56M
Net non-operating interest income expense
-0.56%105.41K
-34.94%84.53K
-24.16%115.3K
31.67%494.23K
-35.11%106.27K
-30.87%106K
116.91%129.93K
9,308.66%152.04K
2,904.06%375.36K
61,239.70%163.78K
Non-operating interest income
----
----
----
31.67%494.23K
----
----
----
----
--375.36K
----
Total other finance cost
0.56%-105.41K
34.94%-84.53K
24.16%-115.3K
----
----
30.87%-106K
---129.93K
-9,308.66%-152.04K
----
----
Other net income (expense)
-247.37%-121.14K
27.61%-43.58K
725.73%268.08K
-346.89%-429.35K
-105.34%-408.51K
89.00%82.2K
-249.69%-60.2K
-323.58%-42.84K
-31.75%-96.07K
-911.13%-198.94K
Gain on sale of security
-247.37%-121.14K
27.61%-43.58K
725.73%268.08K
-346.89%-429.35K
-105.34%-408.51K
89.00%82.2K
-249.69%-60.2K
-323.58%-42.84K
-31.75%-96.07K
-911.13%-198.94K
Income before tax
4.73%-4.47M
-6.27%-8.14M
21.99%-3.99M
-26.81%-22.19M
-2.46%-4.71M
-3.13%-4.7M
-50.93%-7.66M
-56.55%-5.12M
-26.00%-17.5M
-42.38%-4.6M
Income tax
-48.76%10.99K
-95.45%1.21K
18.81%19.87K
-14.74%79.28K
-81.43%14.5K
430.04%21.46K
190.72%26.59K
897.50%16.73K
2,219.76%92.98K
1,047.42%78.11K
Net income
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-26.59%-22.27M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-26.64%-17.59M
-45.17%-4.67M
Net income continuous Operations
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-26.59%-22.27M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-26.64%-17.59M
-45.17%-4.67M
Minority interest income
Net income attributable to the parent company
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-26.59%-22.27M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-26.64%-17.59M
-45.17%-4.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-26.59%-22.27M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-26.64%-17.59M
-45.17%-4.67M
Basic earnings per share
54.05%-0.17
32.26%-0.42
48.84%-0.22
-15.54%-1.71
25.64%-0.29
2.63%-0.37
-44.19%-0.62
-53.57%-0.43
-8.03%-1.48
-50.00%-0.39
Diluted earnings per share
54.05%-0.17
32.26%-0.42
48.84%-0.22
-15.54%-1.71
25.64%-0.29
2.63%-0.37
-44.19%-0.62
-53.57%-0.43
-8.03%-1.48
-50.00%-0.39
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-60.62%55.18K00022.61%55.18K-15.08%140.11K0
Operating revenue --0--0--0-58.40%55.18K--0--0--047.00%55.18K-0.96%132.64K--0
Cost of revenue
Gross profit
Operating expense -8.72%4.46M5.84%8.18M-17.17%4.38M24.51%22.31M-3.38%4.41M2.82%4.89M46.66%7.73M58.54%5.28M28.06%17.92M40.26%4.56M
Selling and administrative expenses -27.02%1.84M0.05%3.75M-24.98%1.87M13.08%10.79M-11.11%2.03M-9.64%2.52M39.19%3.74M40.33%2.49M39.74%9.54M28.54%2.29M
-General and administrative expense -27.02%1.84M0.05%3.75M-24.98%1.87M13.08%10.79M-11.11%2.03M-9.64%2.52M39.19%3.74M40.33%2.49M39.74%9.54M28.54%2.29M
Research and development costs 10.74%2.62M11.28%4.44M-10.19%2.51M37.52%11.52M4.40%2.37M20.50%2.37M54.44%3.99M79.33%2.79M16.93%8.38M54.42%2.27M
Operating profit 8.72%-4.46M-5.84%-8.18M16.29%-4.38M-25.18%-22.25M3.38%-4.41M-2.82%-4.89M-49.35%-7.73M-59.03%-5.23M-28.58%-17.78M-42.15%-4.56M
Net non-operating interest income expense -0.56%105.41K-34.94%84.53K-24.16%115.3K31.67%494.23K-35.11%106.27K-30.87%106K116.91%129.93K9,308.66%152.04K2,904.06%375.36K61,239.70%163.78K
Non-operating interest income ------------31.67%494.23K------------------375.36K----
Total other finance cost 0.56%-105.41K34.94%-84.53K24.16%-115.3K--------30.87%-106K---129.93K-9,308.66%-152.04K--------
Other net income (expense) -247.37%-121.14K27.61%-43.58K725.73%268.08K-346.89%-429.35K-105.34%-408.51K89.00%82.2K-249.69%-60.2K-323.58%-42.84K-31.75%-96.07K-911.13%-198.94K
Gain on sale of security -247.37%-121.14K27.61%-43.58K725.73%268.08K-346.89%-429.35K-105.34%-408.51K89.00%82.2K-249.69%-60.2K-323.58%-42.84K-31.75%-96.07K-911.13%-198.94K
Income before tax 4.73%-4.47M-6.27%-8.14M21.99%-3.99M-26.81%-22.19M-2.46%-4.71M-3.13%-4.7M-50.93%-7.66M-56.55%-5.12M-26.00%-17.5M-42.38%-4.6M
Income tax -48.76%10.99K-95.45%1.21K18.81%19.87K-14.74%79.28K-81.43%14.5K430.04%21.46K190.72%26.59K897.50%16.73K2,219.76%92.98K1,047.42%78.11K
Net income 4.93%-4.49M-5.92%-8.14M21.86%-4.01M-26.59%-22.27M-1.06%-4.72M-3.51%-4.72M-51.18%-7.69M-56.98%-5.14M-26.64%-17.59M-45.17%-4.67M
Net income continuous Operations 4.93%-4.49M-5.92%-8.14M21.86%-4.01M-26.59%-22.27M-1.06%-4.72M-3.51%-4.72M-51.18%-7.69M-56.98%-5.14M-26.64%-17.59M-45.17%-4.67M
Minority interest income
Net income attributable to the parent company 4.93%-4.49M-5.92%-8.14M21.86%-4.01M-26.59%-22.27M-1.06%-4.72M-3.51%-4.72M-51.18%-7.69M-56.98%-5.14M-26.64%-17.59M-45.17%-4.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.93%-4.49M-5.92%-8.14M21.86%-4.01M-26.59%-22.27M-1.06%-4.72M-3.51%-4.72M-51.18%-7.69M-56.98%-5.14M-26.64%-17.59M-45.17%-4.67M
Basic earnings per share 54.05%-0.1732.26%-0.4248.84%-0.22-15.54%-1.7125.64%-0.292.63%-0.37-44.19%-0.62-53.57%-0.43-8.03%-1.48-50.00%-0.39
Diluted earnings per share 54.05%-0.1732.26%-0.4248.84%-0.22-15.54%-1.7125.64%-0.292.63%-0.37-44.19%-0.62-53.57%-0.43-8.03%-1.48-50.00%-0.39
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%

Unlock the Full List